Steven Neier, PhD, Principal
Steven joined Binney Street Capital as a Principal after serving in both scientific and business development roles and alliance manager for Dana-Farber's collaboration with MPM Capital.
Steven is an experienced scientist who has developed and translated multiple novel technologies from academia into biotech. He has helped launch and provided scientific, corporate strategy, and business development support for numerous companies, including NextRNA Therapeutics, Dynamic Cell Therapies AI Proteins, and Microbial Machines.
Steven received his PhD in Immunology from the Mayo Clinic and completed his postdoctoral work at Dana-Farber under Dr. Carl Novina. He received a BS in mathematics, Phi Beta Kappa & Summa Cum Laude, from Union College.
Steven joined Binney Street Capital as a Principal after serving in both scientific and business development roles and alliance manager for Dana-Farber's collaboration with MPM Capital.
Steven is an experienced scientist who has developed and translated multiple novel technologies from academia into biotech. He has helped launch and provided scientific, corporate strategy, and business development support for numerous companies, including NextRNA Therapeutics, Dynamic Cell Therapies AI Proteins, and Microbial Machines.
Steven received his PhD in Immunology from the Mayo Clinic and completed his postdoctoral work at Dana-Farber under Dr. Carl Novina. He received a BS in mathematics, Phi Beta Kappa & Summa Cum Laude, from Union College.